undefined

Jared Holtz

Healthcare equity strategist at Mizuho who analyzes pharmaceutical market dynamics and provided expertise on Novo Nordisk's oral GLP-1 (Wegovy) launch, pricing, and competitive landscape.

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app